O. Cohen

发表

Rapidly progressive Creutzfeldt–Jakob disease in patients with Familial Mediterranean Fever

J. Chapman, I. Prohovnik, E. Pras, 2010, European journal of neurology.

CSF Tau Protein in Alzheimer’s Disease and other Neurological and Psychiatric Diseases

A. Korczyn, Shenker, O. Abramsky, 2015 .

Austin Alzheimer’s and Parkinson’s Disease Initial Experience with Levodopa Intestinal Gel for Advanced Parkinson’s Disease

O. Cohen, Faust-Socher, S.I. Lerman, 2015 .

The European Prader-Willi Syndrome Clinical Research Database: an aid in the investigation of a rare genetically determined neurodevelopmental disorder.

A. Holland, B. Horsthemke, L. Curfs, 2009, Journal of intellectual disability research : JIDR.

Enhanced Detection of Diffusion Reductions in Creutzfeldt-Jakob Disease at a Higher B Factor

P. Kingsley, I. Prohovnik, Hedok Lee, 2010, American Journal of Neuroradiology.

Exploring determinants of progression in Parkinson's disease. Is there a difference among Jewish ethnic groups?

U. Goldbourt, R. Inzelberg, S. Hassin-Baer, 2015, Parkinsonism & related disorders.

CSF tau correlates with CJD disease severity and cognitive decline

J. Chapman, S. Appel, H. Rosenmann, 2016, Acta neurologica Scandinavica.

Unusual presentations in patients with E200K familial Creutzfeldt−Jakob disease

J. Chapman, E. Kahana, C. Hoffmann, 2016, European journal of neurology.

The Creutzfeldt–Jakob disease (CJD) neurological status scale: a new tool for evaluation of disease severity and progression

J. Chapman, I. Prohovnik, Sarit Appel, 2011, Acta neurologica Scandinavica.

Cerebral White Matter Disruption in Creutzfeldt-Jakob Disease

J. Chapman, P. Kingsley, I. Prohovnik, 2012, American Journal of Neuroradiology.

The role of apolipoprotein E polymorphisms in levodopa‐induced dyskinesia

J. Chapman, S. Hassin-Baer, A. Katzav, 2011, Acta neurologica Scandinavica.